These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12493481)

  • 1. Murine heart transgenic Fas ligand expression protects against allograft rejection.
    Zuraff-Perryman LA; Duke RC; Setser E; Nelson DP; Bellgrau D
    Transplant Proc; 2002 Dec; 34(8):3396-8. PubMed ID: 12493481
    [No Abstract]   [Full Text] [Related]  

  • 2. Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection.
    Plenter RJ; Grazia TJ; Nelson DP; Zamora MR; Gill RG; Pietra BA
    Cell Immunol; 2015 Jan; 293(1):30-3. PubMed ID: 25497973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Fas ligand to cardiac allograft rejection.
    Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
    Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligand-CD40 T cell costimulation pathway is required for host sensitization in the immune cascade leading to accelerated allograft rejection.
    Kupiec-Weglinski JW; Shen XD; Gao F; Zhai Y; Coito AJ; Sayegh MH
    Transplant Proc; 2001; 33(1-2):304-5. PubMed ID: 11266829
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
    Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G
    J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunosuppression of the indirect recognition pathway.
    Suciu-Foca N; Cortesini R
    Transplant Proc; 1998 Dec; 30(8):4060-1. PubMed ID: 9865294
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic pathways in a quantitative model of immunosuppression based on rejection of an allogeneic or xenogeneic tumor graft.
    Hammond-McKibben D; Saulnier M; Zhang J; Risher N; Lake P; Weetall M
    Transplantation; 2005 Apr; 79(8):889-96. PubMed ID: 15849540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
    He G; Hart J; Thistlethwaite JR; Newell KA
    Transplant Proc; 1998 Sep; 30(6):2592-3. PubMed ID: 9745505
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses?
    Larsen CP; Alexander DZ; Hendrix R; Ritchie SC; Pearson TC
    Transplantation; 1995 Aug; 60(3):221-4. PubMed ID: 7544034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the effect of indoleamine 2,3-dioxygenase on murine mixed lymphocyte reactions and skin allograft rejection.
    Sakurai K; Zou JP; Torres NI; Tschetter JR; Kim HS; Shearer GM
    Transplant Proc; 2002 Dec; 34(8):3271-3. PubMed ID: 12493443
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
    Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
    J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts.
    Borson ND; Strausbauch MA; Kennedy RB; Oda RP; Landers JP; Wettstein PJ
    Transplantation; 1999 Mar; 67(5):672-80. PubMed ID: 10096521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect allorecognition is involved in both acute and chronic allograft rejection.
    Fluck N; Witzke O; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):842-3. PubMed ID: 10083366
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection.
    Rolls HK; Kishimoto K; Illigens BM; Dong V; Sayegh MH; Benichou G; Fedoseyeva EV
    Transplant Proc; 2001; 33(7-8):3821-2. PubMed ID: 11750627
    [No Abstract]   [Full Text] [Related]  

  • 18. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
    Stuart PM; Griffith TS; Usui N; Pepose J; Yu X; Ferguson TA
    J Clin Invest; 1997 Feb; 99(3):396-402. PubMed ID: 9022072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated rejection of Fas ligand-expressing heart grafts.
    Takeuchi T; Ueki T; Nishimatsu H; Kajiwara T; Ishida T; Jishage K; Ueda O; Suzuki H; Li B; Moriyama N; Kitamura T
    J Immunol; 1999 Jan; 162(1):518-22. PubMed ID: 9886428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of L(d+) transgenic mouse hearts.
    Margenthaler JA; Tu F; Otomo N; Shimizu Y; Yu S; Flye MW
    Surgery; 2001 Aug; 130(2):217-24. PubMed ID: 11490352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.